University Children Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Balwierz, Walentyna
ChIm-NB-PL, NCT05272371 / 2021-003832-96: Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease

Recruiting
1
20
Europe
Chemoimmunotherapy (Dinutuximab beta in combination with chemotherapy)
Jagiellonian University, Medicinal Research Agency
High-Risk Neuroblastoma
09/26
12/26
NCT04253015: A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

Recruiting
N/A
125
Europe
Data-collection
EusaPharma (UK) Limited, United BioSource, LLC
Neuroblastoma
03/32
06/32

Download Options